Sign in

CIK 0001111485 · Accelerated filer

RxSight, Inc.

Sign in to watch
Ticker
RXST
Exchange
Nasdaq
Industry
Ophthalmic Goods
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943268801
Phone
949-521-7822
Business address
100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
Former names
CALHOUN VISION INC
  1. 4 Grant or award Director acquired 2,554 shares (grant or award)
  2. 4 Grant or award Director acquired 2,554 shares (grant or award)
  3. 4 Grant or award Director acquired 2,554 shares (grant or award)
  4. 4 Grant or award Director acquired 2,554 shares (grant or award)
  5. 4 Open-market buy Director bought 5,000 shares at $61.09 ($305,457)
  6. 4 Option exercise Chief Operating Officer acquired 24,771 shares (option exercise)
  7. 4 Planned sale President & CEO sold 40,000 shares at $60.15 ($2,405,872)
  8. 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $52.69 ($526,913)
  9. 4 Planned sale Chief Financial Officer sold 20,000 shares at an average $49.90 ($997,946)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $56.37 ($563,726)
  15. 4 Planned sale Chief Operating Officer sold 25,000 shares at an average $54.00 ($1,350,000)
  16. 4 Open-market buy Director bought 8,000 shares at an average $50.83 ($406,673)
  17. 4 Planned sale Chief Operating Officer sold 10,365 shares at an average $50.74 ($525,939)
  18. 4 Gift Director gave 53,967 shares (gift)
  19. 4 Open-market sale Chief Financial Officer sold 25,000 shares at an average $47.31 ($1,182,660)
  20. 4 Open-market sale Director sold 28,250 shares at an average $49.67 ($1,403,120)

Page 5 of 11 · 208 filings